entinostat has been researched along with Acute Confusional Senile Dementia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y | 1 |
| Lin, S | 1 |
| Gu, Z | 1 |
| Chen, L | 1 |
| He, B | 1 |
| Badrikoohi, M | 1 |
| Esmaeili-Bandboni, A | 1 |
| Babaei, P | 1 |
| Zhang, ZY | 1 |
| Schluesener, HJ | 1 |
1 review available for entinostat and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Zinc-dependent deacetylases (HDACs) as potential targets for treating Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Neoplasms; Zi | 2022 |
2 other studies available for entinostat and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Simultaneous administration of bromodomain and histone deacetylase I inhibitors alleviates cognition deficit in Alzheimer's model of rats.
Topics: Alzheimer Disease; Animals; Azepines; Behavior, Animal; Benzamides; CREB-Binding Protein; Disease Mo | 2022 |
Oral administration of histone deacetylase inhibitor MS-275 ameliorates neuroinflammation and cerebral amyloidosis and improves behavior in a mouse model.
Topics: Administration, Oral; Alzheimer Disease; Amyloidosis; Animals; Behavior, Animal; Benzamides; Brain; | 2013 |